Search by Drug Name or NDC

    NDC 42291-0505-01 Methotrexate 2.5 mg/1 Details

    Methotrexate 2.5 mg/1

    Methotrexate is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by AvKARE. The primary component is METHOTREXATE SODIUM.

    Product Information

    NDC 42291-0505
    Product ID 42291-505_0e901544-2f8b-ce0f-e063-6294a90ae5a1
    Associated GPIs 21300050100310
    GCN Sequence Number 036872
    GCN Sequence Number Description methotrexate sodium TABLET 2.5 MG ORAL
    HIC3 V1B
    HIC3 Description ANTINEOPLASTIC - ANTIMETABOLITES
    GCN 38489
    HICL Sequence Number 003905
    HICL Sequence Number Description METHOTREXATE SODIUM
    Brand/Generic Generic
    Proprietary Name Methotrexate
    Proprietary Name Suffix n/a
    Non-Proprietary Name Methotrexate
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET
    Route ORAL
    Active Ingredient Strength 2.5
    Active Ingredient Units mg/1
    Substance Name METHOTREXATE SODIUM
    Labeler Name AvKARE
    Pharmaceutical Class Folate Analog Metabolic Inhibitor [EPC], Folic Acid Metabolism Inhibitors [MoA]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA210040
    Listing Certified Through 2025-12-31

    Package

    NDC 42291-0505-01 (42291050501)

    NDC Package Code 42291-505-01
    Billing NDC 42291050501
    Package 100 TABLET in 1 BOTTLE (42291-505-01)
    Marketing Start Date 2020-10-05
    NDC Exclude Flag N
    Pricing Information N/A